The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if deals are reached, almost assure billions of dollars in savings for taxpayers.

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule.

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list.

The first 10 drugs the Biden administration selected for negotiations cost nearly 8 million Medicare recipients $3.4 billion in out-of-pocket costs in 2022, according to the administration.

Biden administration adds 15 drugs to Medicare price negotiation list Published: Jan. 17, 2025, 1:58 p.m. FILE - The injectable drug Ozempic is shown, July 1, 2023, in Houston.

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs. By Rebecca Robbins President Trump’s decision to move a ...

Updated January 17, 2025 at 12:49 PM ET. The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation.

The list of 15 drugs in the next round is below, in the order provided by HHS. According to the health department, about 5.3 million people with Medicare prescription drug coverage used at least ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before President-elect Trump’s inauguration. The Centers for Medicare and ...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Pompe Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive ...

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...